I was wondering when John Hohneker would show up again. ArriVent Appoints John Hohneker, M.D., to its Board of Directors May 16, 2024 https://ir.arrivent.com/news-releases/news-release-details/arrivent-appoints-john-hohneker-md-its-board-directors Cheryl Buxton appears to serve as an Independent Director for Wallmine investment advisors. https://wallmine.com/otc/hgen/officer/2051278/cheryl-buxton And we know Kevin Xie's Gracell is now a subsidiary of AstraZeneca, and likely a lenzilumab licensee. I always thought there was an opportunity for us to improve the safety and efficacy of AZ's covid vaccine, in addition to their acquired CAR-T. https://www.astrazeneca.com/media-centre/press-releases/2024/acquisition-of-gracell-completed.html